Féderico A.
García
Publicaciones en las que colabora con Féderico A. García (47)
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
2020
-
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study
AIDS Research and Therapy, Vol. 17, Núm. 1
-
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573
-
Failure to bictegravir and development of resistance mutations in an antiretroviral-experienced patient
Antiviral Research, Vol. 179
-
GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000–2016)
Journal of Infection, Vol. 81, Núm. 4, pp. 600-606
-
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain
HIV Medicine, Vol. 21, Núm. 2, pp. 128-134
-
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations
The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 5, pp. 1294-1300
2019
-
Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
PLoS ONE, Vol. 14, Núm. 9
-
Spatiotemporal characteristics of the largest HIV-1 CRF02_AG outbreak in Spain: Evidence for onward transmissions
Frontiers in Microbiology, Vol. 10, Núm. MAR
-
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice
The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 6, pp. 1693-1700
2018
-
Continued propagation of the CRF19_cpx variant among HIV-positive MSM patients in Spain
Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 4, pp. 1031-1038
-
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
BMC Infectious Diseases, Vol. 18, Núm. 1
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
2017
-
High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach
PLoS ONE, Vol. 12, Núm. 10
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
-
The cobas® HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice
PLoS ONE, Vol. 12, Núm. 4
2016
-
Combined analysis of the prevalence of drug-resistant Hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE)
Journal of Infectious Diseases, Vol. 213, Núm. 1, pp. 39-48